Peptide-doxorubicin conjugate for specific uptake by triple negative breast cancer cells

被引：0
作者：
Ziaei, Elmira [1 ]
机构：
[1] Chapman Univ, Sch Pharm, Laguna Niguel, CA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
176-ORGN
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Multivalency: Key Feature in Overcoming Drug Resistance with a Cleavable Cell-Penetrating Peptide-Doxorubicin Conjugate
    Marco Lelle
    Christoph Freidel
    Stefka Kaloyanova
    Klaus Müllen
    Kalina Peneva
    International Journal of Peptide Research and Therapeutics, 2018, 24 : 355 - 367
  • [42] Vasculature targeted chemotherapy: Effect of integrin AV homing peptide-doxorubicin conjugate on the growth of experimental hepatoma.
    Kim, JW
    Yoon, JH
    Lee, HS
    Kim, CY
    GASTROENTEROLOGY, 2000, 118 (04) : A907 - A907
  • [43] Comparison of Performance of Breast Specific Markers in Triple Negative Breast Cancer
    Carabano, Miguel
    Yu, Christine
    Lu, Shaolei
    Wang, Li Juan
    Yakirevich, Evgeny
    Wang, Yihong
    LABORATORY INVESTIGATION, 2024, 104 (03) : S127 - S128
  • [44] Peptide-modified bioresponsive chondroitin sulfate micelles for targeted doxorubicin delivery in triple-negative breast cancer
    Yu, Jingmou
    Wang, Liangliang
    Ling, Yun
    Xiao, Xin
    Gong, Juntao
    Jin, Hongguang
    Xu, Jing
    Chen, Pu
    Xie, Xin
    Zhang, Lei
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2023, 227
  • [45] Trojan-Like Peptide Drug Conjugate Design and Construction for Application in Treatment of Triple-Negative Breast Cancer
    Xiao, Chuanguang
    Han, Jieru
    Bai, Jixiang
    Xia, Yanjie
    Wang, Shuhui
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2021, 17 (08) : 1554 - 1563
  • [46] New docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer.
    Demeule, Michel
    Annabi, Borhane
    Currie, Jean-Christophe
    Larocque, Alain
    Charfi, Cyndia
    Beliveau, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
    Hum, Nicholas R.
    Sebastian, Aimy
    Martin, Kelly A.
    Rios-Arce, Naiomy D.
    Gilmore, Sean F.
    Gravano, David M.
    Wheeler, Elizabeth K.
    Coleman, Matthew A.
    Loots, Gabriela G.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Quantification of immune cells in triple negative and non-triple negative of breast cancer
    Sikandar, B.
    VIRCHOWS ARCHIV, 2016, 469 : S23 - S23
  • [49] ROLE OF CISPLATIN AND DOXORUBICIN AS NEOADJUVANT IN LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Athar, Azka
    BREAST, 2018, 41 : S21 - S21
  • [50] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Xia Zhang
    Weijun Bai
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 655 - 659
12345